Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D

Thrombosis and Haemostasis

Volumn 79, Issue 3, 1998, Pages 614-619

  Sugidachi, Atsuhiro ^a   Ogawa, Taketoshi ^a   Asai, Fumitoshi ^a   Saito, Shinya ^b   Ozaki, Hiroshi ^b   Fusetani, Nobuhiro ^b   Karaki, Hideaki ^b   Koike, Hiroyuki ^a  

^a DAIICHI SANKYO CO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTITHROMBOCYTIC AGENT; CALCIUM ION; COLLAGEN; CYTOCHALASIN C; DEOXYRIBONUCLEASE I; FIBRIN; G ACTIN; MYCALOLIDE B; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FIBRIN CLOT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0031951627     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614955     Document Type: Article

References (40)

1. Fox JE, Phillips DR. Polymerization and organization of actin filaments within platelets. Semin Hematol 1983; 20: 243-60.
2. Heptinstall S, Glenn J, Spangenberg P. Changes in G-actin after platelet activation in platelet rich plasma. Thromb Haemost 1992; 68: 727-30.
3. Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol 1987; 105: 1473-8.
4. Franki N, Ding G, Gao Y, Hays RM. Effect of cytochalasin D on the actin cytoskeleton of the toad bladder epithelial cell. Am J Physiol 1992; 263: C995-1000.
5. Wright G, Hum E. Cytochalasin inhibition of slow tension increase in rat aortic rings. Am J Physiol 1994; 267: H1437-46.
6. Fox JE, Phillips DR. Inhibition of actin polymerization in blood platelets by cytochalasins. Nature 1981; 292: 650-2.
7. Tellam R, Frieden C. Cytochalasin D and platelet gelsolin accelerate actin polymer formation. A model for regulation of the extent of actin polymer formation in vivo. Biochemistry 1982; 21: 3207-14.
8. Haslam RJ, Davidson MM, McClenaghan MD. Cytochalasin B. the blood platelet release reaction and cyclic GMP. Nature 1975; 253: 455-7.
9. Peerschke EI. Observations on the effects of Cytochalasin B and Cytochalasin D on ADP-and chymotrypsin-treated platelets. Proc Soc Exp Biol Med 1984; 175: 109-15.
10. Oda A, Daley JF, Cabral C, Kang JH, Smith M, Salzman EW. Heterogeneity in filamentous actin content among individual human blood platelets. Blood 1992; 79: 920-7.
11. Lefebvre P, White JG, Krumwiede MD, Cohen, I. Role of actin in platelet function. Eur J Cell Biol 1993; 62: 194-204.
12. 2+. Semin Thromb Hemost 1995; 21: 137-45.
13. syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization. Thromb Haemost 1996; 75: 648-54.
14. Fusetani N, Yasumuro K, Matsunaga S, Hashimoto K. Mycalolide A-C, hybrid macrolide of ulapualides and halichondramide, from a sponge of the genous mycale. Tetrahedron Lett 1989; 30: 2809-12.
15. Hori M, Saito S, Shin YZ, Ozaki H, Fusetani N, Karaki H. Mycalolide-B, a novel and specific inhibitor of actomyosin ATPase isolated from marine sponge. FEBS Lett 1993; 322: 151-4.
16. Saito S, Watabe S, Ozaki H, Fusetani N, Karaki, H. Mycalolide B, a novel actin depolymerizing agent. J Biol Chem 1994; 269: 29710-4.
17. Saito S, Watabe S, Ozaki H, Kigoshi H, Yamada K, Fusetani N, Karaki H. Novel actin depolymerizing maclolide Aplyronine A. J Biochem 1996; 120: 552-5.
18. 2+ mobilization and aggregatory response to ADP and thrombin in aged rat platelets. Platelets 1995; 6: 388-93.
19. Sugidachi A, Breiter N, Ogawa T, Asai F, Koike H. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: Possible mechanism for antiplatelet action. Thromb Haemost 1996; 76: 786-90.
20. Holme TC, Kellie S, Wyke JA, Crawford N. Effect of transformation by Rous sarcoma virus on the character and distribution of actin in Rat-1 fibroblasts: A biochemical and microscopical study. Br J Cancer 1986; 53: 465-76.
21. 2+ mobilization and basal pH level in rat platelets. Platelets 1993; 4: 91-5.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
23. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985; 75: 328-38.
24. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-96.
25. Dwyer SD, Meyers KM. Anesthetics and anticoagulants used in the preparation of rat platelet rich plasma alter rat platelet aggregation. Thromb Res 1986; 42: 139-51.
26. Takahashi O. Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin. Food Chem Toxicol 1991; 29: 173-83.
27. Jung CY, Rampal AL. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts. J Biol Chem 1977; 252: 5456-63.
28. Brenner SL, Korn ED. The effects of cytochalasins on actin polymerization and actin ATPase provide insights into the mechanism of polymerization. J Biol Chem 1980; 255: 841-4.
29. van Deurs B, Behnke O. Membrane structure of nonactivated and activated human blood platelets as revealed by freeze-fracture: evidence for particle redistribution during platelet contraction. J Cell Biol 1980; 87: 209-18.
30. Glenn JR, Spangenberg P, Heptinstall S. Platelet-platelet contact and thromboxane A, contribute to actin polymerization in platelets stimulated with ADP. Platelets 1994; 5: 84-9.
31. Addo JB, Bray PF, Grigoryev D, Faraday N, Goldschmidt-Clermont PJ. Surface recruitment but not activation of integrin αIIbβ3 (GPIIb-IIIa) requires a functional actin cytoskeleton. Arterioscler Thromb Vasc Biol 1995; 15: 1466-73.
32. Gachet C, Cazenave JP. ADP induced blood platelet activation: a review. Nouv Rev Fr Hematol 1991; 33: 347-58.
33. Heemskerk JW, Sage SO. Calcium signaling in platelets and other cells. Platelets 1994; 5: 295-316.
34. 2+ gradients with redistribution of glycoprotein IIb-IIIa and F-actin in activated human blood platelets. Arterioscler Thromb Vasc Biol 1996; 16: 230-5.
35. Phillips DR, Jennings LK, Edwards HH. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol 1980; 86: 77-86.
36. Fox JE. Identification of actin-binding protein as the protein linking the membrane skeleton to glycoproteins on platelet plasma membranes. J Biol Chem 1985; 260: 11970-7.
37. Suzuki H, Tanoue K, Yamazaki H. Morphological evidence for the association of plasma membrane glycoprotein IIb/IIIa with the membrane skeleton in human platelets. Histochemistry 1991 ; 96: 31-9.
38. Gartner TK, Ogilvie ML. Peptides and monoclonal antibodies which bind to platelet glycoproteins IIb and/or IIIa inhibit clot retraction. Thromb Res 1988; 49: 43-53.
39. Cohen I, Burk DL, White JG. The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension. Blood 1989; 73: 1880-7.
40. Fournier DJ, Kabral A, Castaldi PA, Berndt MC. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation. Thromb Haemost 1989; 62: 977-83.